Replies to post #51586 on CV Sciences Inc (CVSI)

[Wolf-man jack]

Sunblazer Thank you for your input. Some say it is the FDA and some day Nasdaq. I believe you are correct that it is Nasdaq. We see that NYSE is allowing cbd companies doing business in the USA. According to this older article I found, it is up to the exchange and not the fda. Thanks for helping me understand this fact and my apologies for the confusion on my part. I was mistaken about Cbdmd being on the Nasdaq. Imo Wolf

https://www.fool.com/investing/2018/11/27/why-dont-more-pot-stocks-list-on-the-nyse-or-nasda.aspx

This article was before the Farm Bill was passed. What is Nasdaq’s Reasoning concerning cbd companies up listing?

The second reason is sort of quirky. Since the U.S. federal government has held firm on its stance of marijuana as a Schedule I substance (i.e., entirely illegal, prone to abuse, and having no recognized medical benefits), the NYSE and Nasdaq have stood their ground on not allowing any marijuana stocks to list on their exchanges that do business in the United States.

Essentially, it's required pot stocks to make a choice: Either uplist to the NYSE or Nasdaq and reap the rewards of improved visibility, validity, and liquidity, but kiss the U.S. market goodbye until the federal government changes its tune, or forget about uplisting and attempt to infiltrate the burgeoning U.S. cannabis market. As a reminder, the U.S. market would probably dwarf Canada as the largest in the world, if it were legalized. Even so, with 32 states having given the green light to medical cannabis in some capacity, and 10 giving the OK to adult-use pot, there's ample opportunity for pot stocks willing to take the risk. This major market opportunity may simply not be worth passing up for some companies.